The Latest Breaking News from FDA

Today's 5 Stock Ideas: Ra Medical Systems (RMED) - Shares up 55.5% premarket. The company announced it has received FDA 510(k) clearance for its DABRA 2.0 catheter. Rubicon Technology (RBCN) - Shares up

The grinding two-plus years of the pandemic have yielded outsize benefits for one company — Pfizer — making it both highly influential and hugely profitable as COVID-19 continues to infect tens of thousands of people and kill hundreds each day.

The Food and Drug Administration (FDA) and narcotics suppression authorities on Monday inspected more than 40 tonnes of confiscated illegal drugs worth over 34.6 billion baht before they are incinerated at a designated facility this week.

Political parties cannot be trusted to deal with misbehaviour by their own MPs, claim general secretaries

Medication abortions were the preferred method for ending pregnancy in the U.S. even before the Supreme Court overturned Roe v. Wade

White House touts abortion pill as answer to Roe reversal but FDA rules limit use

HC Wainwright initiated coverage on NRx Pharmaceuticals Inc (NASDAQ:NRXP) with a Buying rating and a price target of $2. Earlier today, the FDA declined to issue an Emergency Use Authorization for NRx's Zyesami for a subgroup of patients who also received Gilead Sciences Inc's (NASDAQ:GILD) remdesivir in addition to Zyesami. The analyst is bullish on: Significant potential for NRX-101 for…

Discreet and available by mail, abortion-inducing pills could make conservative abortion bans challenging to enforce.

Time for a new Operation Warp Speed?

Here's a roundup of top developments in the biotech space over the last 24 hours:

The U.S.